Differential expression of metallothioneins (MTs) 1, 2, and 3 in response to zinc treatment in human prostate normal and malignant cells and tissues-9

-MT1/2 antibody, and β-actin was used as an internal control (top panel). The density of specific signals of MT1/2 was analyzed and data are presented in lower panel. The different letters (a, b, c) represent the statistical significance (p < 0.05).<p><b>Copyright information:</b></p><p>Taken from "Differential expression of metallothioneins (MTs) 1, 2, and 3 in response to zinc treatment in human prostate normal and malignant cells and tissues"</p><p>http://www.molecular-cancer.com/content/7/1/7</p><p>Molecular Cancer 2008;7():7-7.</p><p>Published online 21 Jan 2008</p><p>PMCID:PMC2265743.</p><p></p>